gression it may be necessary to increase treatment with proton pump inhibitors in patients with Barrett's Esophagus the authors write. Elucidating the pathways leading from acid exposure to increased ROS production increased proliferation and decreased apoptosis may provide a number of potentially useful therapeutic targets the authors write. Source: EurekAlert